AIM ImmunoTech Inc.
AIM
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$0.57
FAIR PRICE
$0.84
MARGIN
$0.27
P/E Ratio
N/A
Div. Yield
N/A
ROE
353.9%
Exceptional
Market Cap
$2M
Small-cap
COMING SOON
Get notified when AIM's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Thomas K. Equels
COUNTRY
US
HEADQUARTERS
Ocala
SECTOR
Healthcare
EXCHANGE
AMEX
METHODOLOGY
How we calculate AIM's fair price
AIM ImmunoTech Inc.'s fair price of $0.84 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $0.57, AIM trades 48.0% below its calculated fair value.
DCF MODEL · 50%
Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting AIM's risk profile.
RELATIVE · 30%
Comparing AIM's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.
ANALYST · 20%
Aggregated analyst price targets for AIM, weighted by recency and analyst accuracy.
TRY IT YOURSELF
Want to test your own assumptions? Use our free calculators to estimate AIM's fair value with your own inputs.
LEARN MORE
POWERED BY BULIOS
Get full analysis, financials, and AI insights for AIM.
Explore on BuliosFAQ
What is the fair price of AIM?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for AIM ImmunoTech Inc. is $0.84. At the current market price of $0.57, AIM trades 48.0% below its calculated fair value.
Is AIM overvalued or undervalued?+
AIM ImmunoTech Inc. is currently undervalued based on our valuation model. The stock trades at $0.57, which is 48.0% below the fair price of $0.84.
How often is AIM's fair price updated?+
We update fair price calculations for AIM daily after market close. The current fair price of $0.84 incorporates the latest market data and sector multiples.
What factors affect AIM's fair price calculation?+
AIM's fair price of $0.84 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of 353.9%.
Is AIM a good buy right now?+
At $0.57, AIM trades 48.0% below our fair value estimate of $0.84. The stock is currently undervalued. ROE stands at 353.9% (exceptional). Fair Price Index provides valuation data — always do your own research before investing.
Does AIM pay dividends?+
AIM does not currently pay a dividend.
RELATED STOCKS
Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.